期刊文献+

抗环瓜氨酸肽抗体和葡萄糖-6-磷酸-异构酶抗原对类风湿关节炎诊断价值的比较 被引量:13

Study on the diagnostic value of anti-cyclic citrullinated peptide antibodies and glucose-6-phosphate isomerase for rheumatoid arthritis
原文传递
导出
摘要 目的评价抗环瓜氨酸肽(CCP)抗体和葡萄糖-6-磷酸-异构酶(GPI)抗原对类风湿关节炎(RA)的诊断价值。方法用酶联免疫吸附试验(ELISA)法分别测定RA患者112例、非RA其他风湿病患者44例以及健康志愿者119名血清中的抗CCP抗体、GPI抗原和IgM—RF,应用ROC比较抗CCP抗体和GPI抗原对RA的诊断价值,用Spearman方法分析上述指标与lgM—RF的相关性。结果在诊断RA时.抗CCP抗体和GPI抗原的ROC曲线下面积均大于IgM—RF(P均〈0.05)。抗CCP抗体、GPI抗原与IgM—RF显著相关。CCP抗体与GPI抗原的联合试验的灵敏度达到0.946。结论联合测定抗CCP抗体和GPI抗原对RA具有较高的诊断价值,具有良好的应用前景。 Objective To assess the diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) and glucose-6-phosphate isomerase (GPI) for rheumatoid arlhritis (RA). Methods The level of serum anti-CCP, GPI and IgM-RF in 112 patients with RA, 44 patients with other rheumatic diseases and 119 normal controls were determined by ELISA. The diagnostic value of these two antibodies for RA were compared by receiver operating characteristic curve (ROC). The correlation between these antibodies and IgM-RF was assessed by Spearman. Results For the diagnosis of RA, the area under curve of anti-CCP and GPI was sig- nificantly larger than that of IgM-RF. Anti-CCP and GPI was correlated with IgM-RF. Conclusion The level of serum anti-CCP and GPI have high value in diagnosing RA.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第1期33-35,共3页 Chinese Journal of Rheumatology
基金 上海市卫生局科研资助项目(99428)
关键词 关节炎 类风湿 抗环瓜氨酸肽抗体 葡萄糖-6-磷酸-异构酶抗原 Arthritis, rheumatoid Anti-cyclic cltrullinated peptide antibodies Glueose-6-phosphate
  • 相关文献

参考文献10

二级参考文献37

  • 1谢其冰,刘钢,王兰兰,彭晓东,杨南萍.抗环瓜氨酸肽抗体在类风湿关节炎诊断中的意义及对关节侵蚀预测的价值[J].中华风湿病学杂志,2004,8(6):356-360. 被引量:19
  • 2周彬,朱静,刘建,龙武彬,吴晓丹,程佳,吴侗.抗环瓜氨酸肽抗体检测在类风湿关节炎中的诊断及预后意义探讨[J].中华风湿病学杂志,2004,8(6):360-362. 被引量:51
  • 3Paimela L, Gripengerg M, Kurki P, et al. Antikeratin antibodies:diagnostic and prognostic markers for early rheumatoid arthritis.Ann Rheum Dis, 1992, 51: 743-746.
  • 4Gerard A, Schellekens GA, Hendrik V, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclie citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 5Anil V. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab, 2002, 8: 34-36.
  • 6Nicola B, Giovanni M, Elio T, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem,2001, 47: 1089-1093.
  • 7Furst DE. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Dis Clin North Am, 1994, 20:309-319.
  • 8Van Zenben D, Hazes JMW, Zwinderman AH, et al. Factors predicting outcome of rheumatoid arthritis:results of a followup study.J Rheumatol, 1993, 20: 1288-1296.
  • 9Combe B, Eliaou JF, Daures JP, et al. Prognostic factors in rheumatoid arthritis: comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol, 1995,34: 529-534.
  • 10Despres N, Boire G, Lopez-Longo F J, et al. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol, 1994, 21: 1027-1033.

共引文献152

同被引文献91

引证文献13

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部